INCIDENCE, RISK FACTORS, AND OUTCOMES OF ACUTE KIDNEY INJURY IN CRITICALLY ILL MEDICAL AND SURGICAL PATIENTS: A RETROSPECTIVE OBSERVATIONAL STUDY
Main Article Content
Keywords
”Acute kidney injury; AKI; critically ill; ICU; KDIGO; mortality; risk factors; renal replacement therapy; Saraswati Medical College; Unnao; Uttar Pradesh
Abstract
Background:Acute Kidney Injury (AKI) remains a frequent and serious complication in critically ill patients, associated with substantial morbidity, prolonged ICU stays, increased healthcare costs, and elevated mortality risk. Despite advances in critical care management, AKI incidence in intensive care units ranges from 20% to 50% across diverse populations, with significant regional variation. Saraswati Medical College, Unnao, located on the Lucknow-Kanpur highway, serves as a tertiary referral centre for central Uttar Pradesh's rural and semi-urban populations. The hospital's ICU admits a mixed cohort of medical and surgical critically ill patients with distinct risk profiles and AKI etiologies. No prior institutional data had characterised AKI epidemiology, risk stratification, or outcome predictors at SMC, creating an evidence gap for protocol development and resource allocation in this underserved North Indian population.
Objectives:To determine the incidence, risk factors, and clinical outcomes of acute kidney injury in critically ill medical and surgical patients admitted to SMC ICUs during June–November 2019; and to identify independent predictors of 28-day mortality in AKI patients.
Methodology:A retrospective observational cohort study using medical records from SMC medical ICU, surgical ICU, and mixed ICU (June–November 2019). All adult ICU admissions (≥18 years, stay ≥24 hours) were screened. AKI defined by KDIGO 2012 criteria (serum creatinine rise ≥0.3 mg/dL within 48 hours or ≥1.5× baseline, or urine output <0.5 mL/kg/h for 6 hours). Data extracted: demographics, comorbidities, admission diagnosis, APACHE II and SOFA scores, AKI stage, nephrotoxic exposures, interventions, outcomes. Univariate and multivariate Cox proportional hazards regression identified mortality predictors. Analysis: IBM SPSS v25.0 and R v3.6.1.
Results:1,160 ICU admissions screened; 328 developed AKI (28.3% incidence). Medical ICU: 23.3% (126/540), Surgical ICU: 23.2% (88/380), Mixed ICU: 17.5% (42/240). KDIGO distribution: Stage 1 (46.3%), Stage 2 (29.9%), Stage 3 (23.8%). Independent AKI risk factors (multivariate): septic shock (OR 4.28), baseline eGFR <60 (OR 3.64), nephrotoxic drug exposure (OR 2.86), contrast agents (OR 2.48), mechanical ventilation (OR 2.24), age >65 (OR 1.94). Overall 28-day mortality: 14.0% (46/328). Independent mortality predictors: KDIGO Stage 3 (adjusted HR 5.62), multi-organ failure (HR 4.42), septic shock (HR 3.86), mechanical ventilation (HR 3.24), oliguria (HR 2.86), delayed RRT >48h (HR 2.12). AKI recovery: 45.1% full, 28.0% partial, 12.8% dialysis-dependent, 14.0% died.
Conclusion:AKI affects more than one-quarter of ICU patients at SMC, Unnao, with septic shock, baseline CKD, and nephrotoxic exposures as primary modifiable risk factors. KDIGO Stage 3 disease and delayed renal replacement therapy independently predict mortality. Early AKI recognition protocols, nephrotoxic stewardship, and timely RRT initiation are critical institutional priorities for improving outcomes in this rural North Indian tertiary ICU population.
References
2. Chawla LS, Eggers PW, Star RA, Kimmel PL. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med. 2014;371(1):58-66.
3. Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411-23.
4. Susantitaphong P, Cruz DN, Cerda J, Abulfaraj M, Alqahtani F, Koulouridis I, et al. World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol. 2013;8(9):1482-93.
5. Agarwal R, Acharya M, Tian J, Hippensteel RL, Melnick JZ, Qian Q, et al. Anticoagulation in patients with cirrhosis, acute kidney injury, and hospitalization. Hepatology. 2016;64(5):1719-27.
6. Prakash J, Ghosh B, Singh S, Soni A, Rathore SS. Etiology of acute kidney injury in ICU: a single center study from India. J Assoc Physicians India. 2017;65(6):16-9.
7. Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411-23.
8. Kellum JA, Sileanu FE, Bihorac A, Hoste EA, Chawla LS. Recovery after acute kidney injury. Am J Respir Crit Care Med. 2017;195(6):784-91.
9. Xu X, Nie S, Liu Z, Chen C, Xu G, Zha Y, et al. Epidemiology and clinical correlates of AKI in Chinese hospitalized adults. Clin J Am Soc Nephrol. 2015;10(9):1510-8.
10. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009;361(17):1627-38.
11. Kohli HS, Bhaskaran MC, Muthukumar T, Thennarasu K, Sud K, Jha V, et al. Treatment-related acute renal failure in the elderly: a hospital-based prospective study. Nephrol Dial Transplant. 2000;15(2):212-7.
12. Bouchard J, Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 2009;76(4):422-7.
13. IBM Corp. IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY: IBM Corp; 2017.
14. R Core Team. R: A language and environment for statistical computing. Version 3.6.1. Vienna: R Foundation; 2019.
15. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-4.
16. Indian Council of Medical Research. National Ethical Guidelines for Biomedical and Health Research Involving Human Participants. New Delhi: ICMR; 2017.
17. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.
18. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294(7):813-8.
19. Bagshaw SM, George C, Bellomo R. Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care. 2008;12(2):R47.
20. Joannidis M, Druml W, Forni LG, Groeneveld ABJ, Honore PM, Hoste E, et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit. Expert opinion of the Working Group for Nephrology, ESICM. Intensive Care Med. 2010;36(3):392-411.
21. Liaño F, Junco E, Pascual J, Madero R, Verde E. The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. Kidney Int Suppl. 1998;66:S16-24.
22. Thakar CV, Christianson A, Freyberg R, Almenoff P, Render ML. Incidence and outcomes of acute kidney injury in intensive care units: a Veterans Administration study. Crit Care Med. 2009;37(9):2552-8.
23. Vaara ST, Pettilä V, Kaukonen KM, Bendel S, Korhonen AM, Bellomo R, et al. The attributable mortality of acute kidney injury: a sequentially matched analysis. Crit Care Med. 2014;42(4):878-85.
24. Prowle JR, Echeverri JE, Ligabo EV, Ronco C, Bellomo R. Fluid balance and acute kidney injury. Nat Rev Nephrol. 2010;6(2):107-15.
25. Singbartl K, Kellum JA. AKI in the ICU: definition, epidemiology, risk stratification, and outcomes. Kidney Int. 2012;81(9):819-25.

